These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 28331317)
1. Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects. Song Z; Lin Y; Zhang X; Feng C; Lu Y; Gao Y; Dong C Int J Nanomedicine; 2017; 12():1941-1958. PubMed ID: 28331317 [TBL] [Abstract][Full Text] [Related]
2. Lipopepsomes: A novel and robust family of nano-vesicles capable of highly efficient encapsulation and tumor-targeted delivery of doxorubicin hydrochloride in vivo. Qiu M; Sun H; Meng F; Cheng R; Zhang J; Deng C; Zhong Z J Control Release; 2018 Feb; 272():107-113. PubMed ID: 29355618 [TBL] [Abstract][Full Text] [Related]
3. Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats. Chen Z; Deng J; Zhao Y; Tao T Int J Nanomedicine; 2012; 7():3803-11. PubMed ID: 22888235 [TBL] [Abstract][Full Text] [Related]
4. cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo. Zhu Y; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z J Control Release; 2016 Jul; 233():29-38. PubMed ID: 27178807 [TBL] [Abstract][Full Text] [Related]
5. The effect of liposomal size on the targeted delivery of doxorubicin to Integrin αvβ3-expressing tumor endothelial cells. Kibria G; Hatakeyama H; Ohga N; Hida K; Harashima H Biomaterials; 2013 Jul; 34(22):5617-27. PubMed ID: 23623323 [TBL] [Abstract][Full Text] [Related]
6. Enhanced uptake and improved anti-tumor efficacy of doxorubicin loaded fibrin gel with liposomal apatinib in colorectal cancer. Hu Y; Wu C; Zhu C; Fu Q; Guo J; Deng L; He Y; Yang D; Cheng Y; Gao X Int J Pharm; 2018 Dec; 552(1-2):319-327. PubMed ID: 30308269 [TBL] [Abstract][Full Text] [Related]
7. Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles. Fang Y; Jiang Y; Zou Y; Meng F; Zhang J; Deng C; Sun H; Zhong Z Acta Biomater; 2017 Mar; 50():396-406. PubMed ID: 28065871 [TBL] [Abstract][Full Text] [Related]
8. Anti-Colorectal Cancer Effect via Application of Polyethylene Glycol Modified Liposomal Apatinib. Hu Y; Zhou P; Lin Y; Yang D; Wang B J Biomed Nanotechnol; 2019 Jun; 15(6):1256-1266. PubMed ID: 31072433 [TBL] [Abstract][Full Text] [Related]
9. Cyclic RGD-Decorated Liposomal Gossypol AT-101 Targeting for Enhanced Antitumor Effect. Liu H; Zhang R; Zhang D; Zhang C; Zhang Z; Fu X; Luo Y; Chen S; Wu A; Zeng W; Qu K; Zhang H; Wang S; Shi H Int J Nanomedicine; 2022; 17():227-244. PubMed ID: 35068931 [TBL] [Abstract][Full Text] [Related]
10. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes. Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178 [TBL] [Abstract][Full Text] [Related]
11. RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells. Shan D; Li J; Cai P; Prasad P; Liu F; Rauth AM; Wu XY Drug Deliv Transl Res; 2015 Feb; 5(1):15-26. PubMed ID: 25787336 [TBL] [Abstract][Full Text] [Related]
12. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma. Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312 [TBL] [Abstract][Full Text] [Related]
13. Cyclo(RGD)-Decorated Reduction-Responsive Nanogels Mediate Targeted Chemotherapy of Integrin Overexpressing Human Glioblastoma In Vivo. Chen W; Zou Y; Zhong Z; Haag R Small; 2017 Feb; 13(6):. PubMed ID: 27865044 [TBL] [Abstract][Full Text] [Related]
14. Failure of active targeting by a cholesterol-anchored ligand and improvement by altering the lipid composition to prevent ligand desorption. Yamamoto S; Sakurai Y; Harashima H Int J Pharm; 2018 Jan; 536(1):42-49. PubMed ID: 29126905 [TBL] [Abstract][Full Text] [Related]
15. α Zhong P; Meng H; Qiu J; Zhang J; Sun H; Cheng R; Zhong Z J Control Release; 2017 Aug; 259():176-186. PubMed ID: 27986551 [TBL] [Abstract][Full Text] [Related]
16. Integrin α Fu S; Zhao Y; Sun J; Yang T; Zhi D; Zhang E; Zhong F; Zhen Y; Zhang S; Zhang S Colloids Surf B Biointerfaces; 2021 May; 201():111623. PubMed ID: 33636597 [TBL] [Abstract][Full Text] [Related]
17. Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region. Amin M; Mansourian M; Koning GA; Badiee A; Jaafari MR; Ten Hagen TLM J Control Release; 2015 Dec; 220(Pt A):308-315. PubMed ID: 26526970 [TBL] [Abstract][Full Text] [Related]
18. A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo. He S; Cen B; Liao L; Wang Z; Qin Y; Wu Z; Liao W; Zhang Z; Ji A Drug Deliv; 2017 Nov; 24(1):471-481. PubMed ID: 28181832 [TBL] [Abstract][Full Text] [Related]
19. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123 [TBL] [Abstract][Full Text] [Related]